Related Experiment Video
Updated: Jun 12, 2026

Growing a Cystic Fibrosis-Relevant Polymicrobial Biofilm to Probe Community Phenotypes
Published on: April 19, 2024
Revealing the dynamics of polymicrobial infections: implications for antibiotic therapy
Geraint B Rogers1, Lucas R Hoffman, Marvin Whiteley
1King's College London, Molecular Microbiology Research Laboratory, Pharmaceutical Science Division, 150 Stamford Street, Franklin-Wilkins Building, King's College London, London, SE1 9NH, UK.
Abstract:
As a new generation of culture-independent analytical strategies emerge, the amount of data on polymicrobial infections will increase dramatically. For these data to inform clinical thinking, and in turn to maximise benefits for patients, an appropriate framework for their interpretation is required. Here, we use cystic fibrosis (CF) lower airway infections as a model system to examine how conceptual and technological advances can address two clinical questions that are central to improved management of CF respiratory disease. Firstly, can markers of the microbial community be identified that predict a change in infection dynamics and clinical outcomes? Secondly, can these new strategies directly characterize the impact of antimicrobial therapies, allowing treatment efficacy to be both assessed and optimized?
Insights
New analytical methods for polymicrobial infections can predict clinical outcomes and assess antimicrobial therapy effectiveness in cystic fibrosis (CF) patients. This framework aids in interpreting complex data for improved CF respiratory disease management.
Area of Science:
- Microbiology
- Infectious Diseases
- Clinical Medicine
Background:
- Culture-independent analyses are generating vast data on polymicrobial infections.
- Interpreting this data requires a robust framework to benefit patient care.
- Cystic fibrosis (CF) lower airway infections serve as a model to develop such a framework.
Purpose of the Study:
- To establish a framework for interpreting data from polymicrobial infections.
- To identify microbial community markers predicting infection dynamics and clinical outcomes in CF.
- To assess the direct characterization of antimicrobial therapy impact for treatment optimization in CF.
Main Methods:
- Utilizing a model system of cystic fibrosis lower airway infections.
- Applying new conceptual and technological advances in culture-independent analyses.
- Examining strategies to identify predictive microbial markers and assess therapeutic impact.
Main Results:
- Emerging analytical strategies are poised to increase data on polymicrobial infections.
- A framework is needed to translate this data into clinical decision-making.
- The study explores the potential of these strategies in CF respiratory disease.
Conclusions:
- New analytical strategies offer opportunities to better understand and manage polymicrobial infections.
- Developing interpretive frameworks is crucial for leveraging big data in clinical settings.
- This approach can lead to improved patient outcomes, particularly in complex diseases like CF.
Related Concept Videos
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Clinical Significance of Antibiotic Resistance
Microbiota Modulation by Antibiotics
Mechanism of Antibiotic Resistance in MRSA
Antibiotic Selection
Development of Antibiotic Resistance

